The efficacy and safety of transcutaneous auricular vagus nerve stimulation in patients with mild cognitive impairment: A double blinded randomized clinical trial
Wang L, Zhang J, Guo C, He J, Zhang S, Wang Y, Zhao Y, Li L, Wang J, Hou L, et al.
Brain Stimulation · 2022
Key finding
After 24 weeks, taVNS significantly improved MoCA scores, verbal learning, naming ability, and sleep quality in patients with mild cognitive impairment, suggesting potential to delay cognitive decline.
- Condition
- Ageing
- Stimulation
- taVNS
- Evidence tier
- Randomised Controlled Trial
- Participants
- 52
Cite this study
Wang, L., Zhang, J., Guo, C., He, J., Zhang, S., Wang, Y., Zhao, Y., Li, L., Wang, J., Hou, L., Li, S., Wang, Y., Hao, L., Zhao, Y., Wu, M., Fang, J., & Rong, P. (2022). The efficacy and safety of transcutaneous auricular vagus nerve stimulation in patients with mild cognitive impairment: A double blinded randomized clinical trial. Brain Stimulation.
Related studies in Ageing
Age as an Effect Modifier of the Effects of Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) on Heart Rate Variability in Healthy Subjects
Gianlorenco et al. · Journal of Clinical Medicine · 2024 · Randomised Controlled Trial
Effect of transcutaneous auricular vagus nerve stimulation on delayed neurocognitive recovery in elderly patients
Zhou et al. · Aging Clinical and Experimental Research · 2022 · Randomised Controlled Trial
Effects of transcutaneous vagus nerve stimulation in individuals aged 55 years or above: potential benefits of daily stimulation
Bretherton et al. · Aging · 2019 · Randomised Controlled Trial
Transcutaneous auricular vagus nerve stimulation boosts associative memory in older individuals
Jacobs et al. · Neurobiology of Aging · 2015 · Randomised Controlled Trial
Summary by Vagus Research. Always consult the primary source for the authoritative record.